BioLife Solutions Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio716.70
P/S Ratio14.649.6510.2113.0327.16
P/B Ratio3.452.172.143.256.36
Price/Tangible Book9.486.467.2515.3411.28
Price/FCF384.00
Price/OCF142.83196.51
Enterprise Value Ratios
EV/Revenue14.649.699.9812.6325.22
EV/EBITDA818.78
EV/FCF384.06
Profitability & Returns
Return on Equity (ROE)-0.03%-0.05%0.00%-0.03%0.02%
Return on Assets (ROA)-0.01%-0.04%-0.01%-0.05%-0.01%
Return on Capital Employed (ROCE)-0.02%-0.07%-0.03%-0.06%-0.02%
Leverage & Solvency Ratios
Debt/Equity0.090.100.120.060.05
Debt/EBITDA19.843.78
Debt/FCF9.62
Liquidity Ratios
Current Ratio4.542.863.112.957.37
Quick Ratio3.481.242.172.186.32
Efficiency Ratios
Asset Turnover0.200.180.150.300.29
Inventory Turnover1.020.960.934.051.79
Yield & Distribution Ratios
Earnings Yield-0.02%-0.09%-0.18%-0.01%0.00%
FCF Yield0.00%-0.03%-0.03%-0.01%0.00%
Buyback Yield-0.05%-0.01%-0.12%-0.41%-0.40%